The American Association of Immunologists has named OMRF’s Paul Kincade to its 2019 class of Distinguished Fellows.
Glioblastoma is an aggressive form of brain cancer with no cure, but a new OMRF discovery offers hope.
OMRF’s Courtney Griffin succeeds OCASCR’s founding scientific director, Paul Kincade, who is retiring.
Two grants will enable OMRF scientists to examine genes thought to play a role in lupus.
The grants will support more than 50 research and clinical projects, purchase scientific equipment and fund recruitment.
As bad as the instant regret can be from a sunburn, the long-term effects pose the most substantial threat.